AbbVie

ABBV NYSE
80.06
-1.09
-1.34%
After Hours: 80.08 +0.02 +0.03% 18:16 05/24 EDT
Open
81.09
Prev Close
81.15
High
81.10
Low
79.87
Volume
3.87M
Avg Vol (3M)
5.54M
52 Week High
104.55
52 Week Low
75.62
% Turnover
0.26%
Market Cap
118.36B
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers AbbVie ABBV stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).
MORE >

Recently

Name
Price
%Change